Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study
Photobiomodulation, Photomedicine, and Laser Surgery · 2026
DOI: 10.1177/25785478261486643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Photobiomodulation, Photomedicine, and Laser Surgery, 2026. Verfasst von Derya Sema Yaman Kalender und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Technologies, Institute of Natural and Applied Sciences, Izmir Katip Celebi University, Izmir, Türkiye. Hauptthemen laut MEDLINE: Photochemotherapy, Indocyanine Green, Pioglitazone, Thyroid Neoplasms. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Türkiye Sağlık Enstitüleri Başkanlığı.
Abstract (Originalsprache)
Purpose
Among thyroid malignancies, papillary thyroid carcinoma (PTC) occurs most frequently, and therapeutic resistance remains a major obstacle in advanced disease. In this study, we evaluated the potential of pioglitazone (PIO), a peroxisome proliferator-activated receptor gamma agonist, to enhance the efficacy of indocyanine green (ICG)-mediated photodynamic therapy (PDT) in B-CPAP human PTC cells.
Methods
After dose optimization, PIO and ICG were tested individually and in combination with laser irradiation (808 nm, 50 J/cm 2 ). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was utilized to assess cell viability, while intracellular reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP) were examined to better elucidate the underlying mechanisms.
Results
PIO alone showed minimal cytotoxicity in B-CPAP cells, whereas ICG–PDT induced a moderate reduction in viability. The combined treatment with 64.5 μM ICG and 509.0 μM PIO under PDT conditions significantly decreased cell survival to ∼50%, resulting in a substantial elevation in ROS levels and disruption of MMP. Importantly, this combination also exhibited cytotoxic effects in a non-malignant thyroid epithelial cell line (Nthy-ori 3-1), though to a lesser extent.
Conclusions
These findings demonstrate that PIO potentiates the antitumor activity of ICG–PDT by inducing oxidative stress and mitochondrial dysfunction. This in vitro approach suggests a rational, combinatorial strategy that merits further investigation in preclinical models of thyroid cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Technologies, Institute of Natural and Applied Sciences, Izmir Katip Celebi University, Izmir, Türkiye.
- Department of Endocrinology and Metabolism, Atatürk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Türkiye.
- Department of Medical Oncology, Atatürk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Türkiye.
- Department of Biomedical Engineering, Faculty of Engineering and Architecture, Izmir Katip Celebi University, Izmir, Türkiye.
ORCID-Profile: Derya Sema Yaman Kalender, Nermin Topaloğlu
Förderung
- Türkiye Sağlık Enstitüleri Başkanlığı
Zitieren
APA
Yaman Kalender, D. S., Kalender, M. E., & Topaloğlu, N. (2026). Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study. Photobiomodulation, Photomedicine, and Laser Surgery. https://doi.org/10.1177/25785478261486643
Vancouver
Yaman Kalender DS, Kalender ME, Topaloğlu N. Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study. Photobiomodulation, Photomedicine, and Laser Surgery. 2026. doi:10.1177/25785478261486643
BibTeX
@article{YamanKalender2026,
author = {Yaman Kalender, Derya Sema and Kalender, Mehmet Eren and Topaloğlu, Nermin},
title = {Therapeutic Potential of Pioglitazone-Augmented Indocyanine Green-Driven Photodynamic Therapy in Papillary Thyroid Cancer: An In Vitro Study},
journal = {Photobiomodulation, Photomedicine, and Laser Surgery},
year = {2026},
doi = {10.1177/25785478261486643}
}
EUVIMED